Shilpa Medicare Ltd

SHILPAMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,902 cr, stock is ranked 478
Moderate RiskStock is 2.77x as volatile as Nifty
542.4022.35 (-3.96%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,902 cr, stock is ranked 478
Moderate RiskStock is 2.77x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
33.17
PB RatioPB Ratio
3.34
Dividend YieldDiv. Yield
0.18%
Sector PESector PE
38.41
Sector PBSector PB
5.14
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation.

Investor PresentationView older 

Oct 29, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021810.50786.96924.85992.11105.25112.26156.13147.78
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.24%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnNov 19, 2021

Shilpa Medicare Limited has informed the Exchange regarding 'Shilpa Medicare Limited, Unit III R&D facility clears US FDA Remote Record Review with no observations.'. | Download

Shilpa Medicare Limited has informed the Exchange regarding 'Shilpa Medicare Limited, Unit III R&D facility clears US FDA Remote Record Review with no observations.'. | Download

Related Party Transactions 
Announced OnNov 13, 2021

Shilpa Medicare Limited has informed the Exchange about related Party Transactions | Download

Shilpa Medicare Limited has informed the Exchange about related Party Transactions | Download

Cash Dividend 
Ex. DateSep 20, 2021

Final • Div/Share: ₹ 1.1

See all events